Literature DB >> 24705438

Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension.

Elizabeth S Muxfeldt1, Victor S Margallo2, Gleison M Guimarães2, Gil F Salles2.   

Abstract

BACKGROUND: Obstructive sleep apnea (OSA) syndromes are strongly associated with resistant hypertension, although this has not been systematically examined. The aim of our study was to investigate the prevalence of OSA and its associated factors in a large cohort of resistant hypertensive patients.
METHODS: A cross-sectional analysis with 422 resistant hypertensive patients (31.3% men; mean age = 62.4±9.9 years) submitted to a full-night polysomnography. The presence of OSA was defined by an apnea-hypopnea index (AHI) >5 per hour and moderate/severe OSA was defined by an AHI >15. Statistical analysis included bivariable comparisons between patients with and without moderate/severe OSA and logistic regressions to assess the independent correlates of OSA severity.
RESULTS: Three-hundred forty-seven patients (82.2%) had OSA, and 234 patients (55.5%) had moderate/severe OSA. Patients with moderate/severe OSA were more frequently elderly and obese men with larger waist and neck circumferences, had higher prevalences of diabetes and left ventricular hypertrophy, and had higher proteinuria than patients with no/mild OSA. No difference was found in plasma aldosterone and renin activity. Nighttime systolic blood pressures and pulse pressures were higher in moderate/severe OSA, with lower nocturnal blood pressure fall. In multivariable logistic regression, male sex, older age, diabetes, obesity, increased waist and neck circumferences, and nighttime systolic blood pressure were the independent correlates of moderate/severe OSA.
CONCLUSIONS: Resistant hypertensive patients had a very high prevalence of OSA, and patients with moderate/severe OSA had an adverse ambulatory BP profile, with higher nighttime systolic blood pressures and pulse pressures and higher prevalence of nondipping patterns. Other correlates of OSA severity were mainly demographic-anthropometric variables. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; hypertension; obstructive sleep apnea; polysomnography; resistant hypertension

Mesh:

Substances:

Year:  2014        PMID: 24705438     DOI: 10.1093/ajh/hpu023

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  36 in total

1.  Ambulatory screening for obstructive sleep apnea in patients with resistant arterial hypertension.

Authors:  Monika Kamasová; Jan Václavík; Tomáš Václavík; Milada Hobzová; Eva Kociánová; Miloš Táborský
Journal:  Sleep Breath       Date:  2017-10-27       Impact factor: 2.816

2.  Sex-dependent influence of endogenous estrogen in pulmonary hypertension.

Authors:  Kirsty M Mair; Audrey F Wright; Nicholas Duggan; David J Rowlands; Martin J Hussey; Sonia Roberts; Josephine Fullerton; Margaret Nilsen; Lynn Loughlin; Matthew Thomas; Margaret R MacLean
Journal:  Am J Respir Crit Care Med       Date:  2014-08-15       Impact factor: 21.405

3.  Performance of NoSAS score versus Berlin questionnaire for screening obstructive sleep apnoea in patients with resistant hypertension.

Authors:  Sara Q C Giampá; Rodrigo P Pedrosa; Carolina C Gonzaga; Adriana Bertolami; Celso Amodeo; Sofia F Furlan; Luiz A Bortolotto; Geraldo Lorenzi-Filho; Luciano F Drager
Journal:  J Hum Hypertens       Date:  2018-05-23       Impact factor: 3.012

4.  The prevalence of obstructive sleep apnea and its association with pregnancy-related health outcomes: a systematic review and meta-analysis.

Authors:  Lina Liu; Guang Su; Shuling Wang; Bingqian Zhu
Journal:  Sleep Breath       Date:  2018-09-25       Impact factor: 2.816

5.  Severity of obstructive sleep apnea and metabolic variables: complex relationship needs comprehensive consideration.

Authors:  Jianrong Hu; Chunlin Tu; Jingxian Sun; Yilin Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-03       Impact factor: 2.503

Review 6.  Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift.

Authors:  L H White; T D Bradley; A G Logan
Journal:  J Hum Hypertens       Date:  2014-10-23       Impact factor: 3.012

Review 7.  Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome.

Authors:  Badhma Valaiyapathi; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

Review 8.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

9.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 10.  Resistant Hypertension Updated Guidelines.

Authors:  Irene Chernova; Namrata Krishnan
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.